The Danish biotech startup Enduro Genetics (“Enduro”) has raised EUR 12m in a series-A investment round led by Supernova Invest, NOON Ventures and Sandwater.
Enduro is a deeptech synthetic biology company redefining bioprocesses with a new optimization technology that unlocks biotechnology’s full potential by boosting already high-performing processes.
The company has developed a genetic plugin that connects high production levels to growth which effectively makes the production strain addicted to production of the desired product. The new funding allows Enduro to expand their platform and to commercialise its technology.
Enduro was founded in 2019 and have since then been working on innovating biomanufacturing by addressing the challenge of microbial productivity.
Accura advised Enduro in connection with the investment.